The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Cancer treatment and survivorship statistics, 2025
Open accessAbstract
The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as improved survival through advances in early detection and treatment. To assist the public health community serve the needs of these survivors, the American Cancer Society and the National Cancer Institute collaborate triennially to estimate cancer prevalence in the United States using data from the Surveillance, Epidemiology, and End Results cancer registries, the Centers for Disease Control and Prevention's National Center for Health Statistics, and the United States Census Bureau. In addition, cancer treatment patterns are presented from the National Cancer Database along with a brief overview of treatment‐related side effects. As of January 1, 2025, about 18.6 million people were living in the United States with a history of cancer, and this number is projected to exceed 22 million by 2035. The three most prevalent cancers are prostate (3,552,460), melanoma of the skin (816,580), and colorectum (729,550) among males and breast (4,305,570), uterine corpus (945,540), and thyroid (859,890) among females. About one half (51%) of survivors were diagnosed within the past 10 years, and nearly four fifths (79%) were aged 60 years and older. Racial differences in treatment in 2021 were common across disease stage; for example, Black people with stage I‐II lung cancer were less likely to undergo surgery than their White counterparts (47% vs. 52%). Larger disparities exist for rectal cancer, for which 39% of Black people with stage I disease undergo proctectomy or proctocolectomy compared to 64% of their White counterparts. Targeted, multi‐level efforts to expand access to high‐quality care and survivorship resources are vital to reducing disparities and advancing support for all survivors of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–223 of 223
Lee, N., Lee, J. L., & Lee, J.-Y. (2023) · Targeted Oncology · doi:10.1007/s11523-023-00951-z · Cited by 20
Incidence of Second Primary Melanoma in Cutaneous Melanoma Survivors
Wiener, A. A., Schumacher, J. R., Racz, J. M., Weber, S. M., Xu, Y. G., & Neuman, H. B. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-11725-8 · Cited by 20
Decreased Use of Sphincter-Preserving Procedures Among African Americans with Rectal Cancer
Arsoniadis, E. G., Fan, Y., Jarosek, S. L., Gaertner, W. B., Melton, G. B., Madoff, R. D., & Kwaan, M. R. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6306-4 · Cited by 19
The 2017 perfect storm season, climate change, and environmental injustice
Shultz, J. M., Kossin, J. P., Ettman, C. K., Kinney, P. L., & Galea, S. (2018) · The Lancet Planetary Health · doi:10.1016/s2542-5196(18)30168-2 · Cited by 19
Physical Health Decline After Chemotherapy or Endocrine Therapy in Breast Cancer Survivors
Bodelón, C., Masters, M., Bloodworth, D. E., Briggs, P. J., Rees‐Punia, E., McCullough, L. E., Patel, A. V., & Teras, L. R. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.62365 · Cited by 19
The Effect of Major and Minor Complications After Lung Surgery on Length of Stay and Readmission
Finley, C., Begum, H., Pearce, K., Agzarian, J., Hanna, W. C., Shargall, Y., & Akhtar‐Danesh, N. (2022) · Journal of Patient Experience · doi:10.1177/23743735221077524 · Cited by 17
Galvao, D. A., Newton, R. U., Taaffe, D. R., Cormie, P., Schumacher, O., Nelson, C. J., Gardiner, R. A., Spry, N. A., Joseph, D. J., Tang, C., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.0413 · Cited by 17
Lindqvist, E. K., Laine, E., Kamali, A., Sars, C., Gillgren, P., & Schultz, I. (2019) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2019.08.011 · Cited by 16
Polter, E. J., Prizment, A. E., Walker, R. F., Ryan, Z., Wang, W., Blaes, A. H., & Lutsey, P. L. (2024) · JACC CardioOncology · doi:10.1016/j.jaccao.2024.08.006 · Cited by 16
Hu, X. Y., Kwon, Y., Jiang, C., Fan, Q., Shi, K. S., Zheng, Z., Zhao, J., Warren, J. L., Yabroff, K. R., & Han, X. (2025) · Journal of Clinical Oncology · doi:10.1200/jco-24-01935 · Cited by 15
Self-citationFarrow, N. E., Turner, M. C., Salama, A. K. S., & Beasley, G. M. (2020) · Oncology and Therapy · doi:10.1007/s40487-020-00117-1 · Cited by 14
Contemporary Patterns of End-of-Life Care Among Medicare Beneficiaries With Advanced Cancer
Kwon, Y., Hu, X. Y., Shi, K. S., Zhao, J., Jiang, C., Fan, Q., Han, X., Zheng, Z., Warren, J. L., & Yabroff, K. R. (2025) · JAMA Health Forum · doi:10.1001/jamahealthforum.2024.5436 · Cited by 14
Self-citationWho Are the Patients in Our Clinical Trials for Cancer?
Freedman, R. A., & Ruddy, K. J. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.00382 · Cited by 12
Washington, S. L., Gregorich, S. E., Meng, M. V., Suskind, A. M., & Porten, S. P. (2020) · Cancer Medicine · doi:10.1002/cam4.3429 · Cited by 12
Minimising the Toxicities of First Line Hodgkin Lymphoma Treatment in the Modern Era
Follows, A. M., & Santarsieri, A. (2022) · Cancers · doi:10.3390/cancers14215390 · Cited by 12
Florez, N., Kiel, L., Meza, K., Wei, Z., Mazzola, E., Velázquez, A. I., Franco, I. “., Fidler, M. J., Elkins, I., Feldman, J., et al. (2023) · Cancer · doi:10.1002/cncr.35057 · Cited by 12
George, D. J., Agarwal, N., Ramaswamy, K., Klaassen, Z. W. A., Bitting, R. L., Russell, D., Sandin, R., Emir, B., Yang, H., Song, W., et al. (2024) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-024-00815-1 · Cited by 10
Rousselot, P. H., Loiseau, C., Delord, M., Besson, C., Cayuela, J., & Spentchian, M. (2019) · Blood · doi:10.1182/blood-2019-129919 · Cited by 9
Fujii, S., Magliocco, A. M., Valtorta, E., Kim, J., Okamoto, W., Kim, J. E., Sawada, K., Nakamura, Y., Torri, V., Kopetz, S., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.36.15_suppl.3594 · Cited by 8
Gielen, A. H. C., & the Guideline Development Group (2024) · United European Gastroenterology Journal · doi:10.1002/ueg2.12658 · Cited by 8
Health-related risk behaviors among U.S. childhood cancer survivors: a nationwide estimate
Nghiem, V. T. H., Jin, J., Mennemeyer, S. T., & Wong, F. L. (2024) · BMC Cancer · doi:10.1186/s12885-024-11894-7 · Cited by 7
Farazi, M. R., Yang, X., Gehl, C. J., Barnett, G. C., Burnet, N. G., Chang-Claude, J. C., Parker, C. C., Dunning, A. M., Azria, D., Choudhury, A., et al. (2025) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-24-1228 · Cited by 7
Patterns of Change in Emotional and Functional Well-Being Following Breast Cancer Diagnosis
Ren, Y., Maselko, J., Tan, X. M., Olshan, A. F., Stover, A. M., Bennett, A. V., Emerson, M. A., & Troester, M. A. (2025) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-24-0849 · Cited by 1
Cited by
Marzi, M., Ghasemian, A., Ghanbariasad, A., Nournia, E., & Zarenezhad, E. (2026) · RSC Advances · doi:10.1039/d5ra09799a
Metadata
- Authors
- Wagle, N. S., Nogueira, L., Devasia, T. P., Mariotto, A. B., Yabroff, K. R., Islami, F., Jemal, A., Alteri, R., Ganz, P. A., & Siegel, R. L.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2025-05-30
- Volume
- 75
- Issue
- 4
- Pages
- 308-340
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W4410893209
- Cited by
- 261
- References
- 223
- FWCI
- 91.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.